| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.471 | 41.442 | 150.678 | 278.415 | 395.877 | 698.848 | 1.596.160 | 1.146.668 | 612.301 | 135.933 |
| Total Income - EUR | 10.471 | 41.442 | 151.082 | 279.046 | 396.097 | 705.112 | 1.749.484 | 1.178.984 | 613.130 | 136.839 |
| Total Expenses - EUR | 10.656 | 22.465 | 115.870 | 307.276 | 374.129 | 504.487 | 1.384.868 | 996.986 | 513.299 | 307.586 |
| Gross Profit/Loss - EUR | -185 | 18.977 | 35.212 | -28.230 | 21.968 | 200.625 | 364.616 | 181.999 | 99.831 | -170.747 |
| Net Profit/Loss - EUR | -499 | 18.559 | 33.705 | -31.017 | 18.010 | 194.066 | 346.613 | 146.361 | 77.142 | -170.747 |
| Employees | 3 | 0 | 31 | 0 | 30 | 26 | 29 | 21 | 12 | 7 |
Check the financial reports for the company - Seroxy 23 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 1.231 | 1.069 | 2.374 | 2.549 | 5.011 | 280.760 | 279.644 | 278.217 |
| Current Assets | 2.909 | 18.596 | 53.220 | 50.525 | 67.829 | 276.199 | 624.886 | 284.781 | 104.765 | 43.021 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.397 |
| Receivables | 0 | 3.831 | 7.649 | 11.404 | 39.190 | 19.280 | 260.210 | 118.339 | 9.431 | 21.441 |
| Cash | 2.909 | 14.765 | 45.571 | 39.121 | 28.638 | 256.918 | 364.676 | 166.442 | 95.334 | 18.183 |
| Shareholders Funds | -2.111 | 16.469 | 33.758 | 1.355 | 19.339 | 212.607 | 565.515 | 146.450 | 132.176 | -39.310 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 81 | 82 | 82 |
| Debts | 5.020 | 2.127 | 22.851 | 50.239 | 50.864 | 66.141 | 67.169 | 419.091 | 252.233 | 360.548 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6391 - 6391" | |||||||||
| CAEN Financial Year |
6312
|
|||||||||
Comments - Seroxy 23 S.r.l.